Evaluation of the Combination of Docetaxel/Carboplatin in Patients with Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck (SCCHN): A Southwest Oncology Group Phase II Study

By Samlowski Wolfram E.   Moon James   Kuebler J. Philip   Nichols Craig R.   Gandara David R.   Ozer Howard   Williamson Stephen K.   Atkins James N.   Schuller David E.   Ensley John F.  

Cancer Investigation, Vol. 25, Iss. 3, 2007-04 ,pp. : 182-188

Informa Healthcare

Access to resources Recommend Favorite

Cilengitide (EMD 121974) arrests the growth of a heavily pretreated highly vascularised head and neck tumour

By Raguse J.-D.   Gath H.J.   Bier J.   Riess H.   Oettle H.  

Oral Oncology, Vol. 40, Iss. 2, 2004-02 ,pp. : 228-230

Elsevier

Access to resources Recommend Favorite

Phase I Study with a Weekly 1 h Infusion of Paclitaxel in Heavily Pretreated Patients with Metastatic Breast and Ovarian Cancer

By Klaassen U.   Wilke H.   Strumberg D.   Eberhardt W.   Korn M.   Seeber S.  

European Journal of Cancer, Vol. 32, Iss. 3, 1996-03 ,pp. : 547-549

Elsevier

Access to resources Recommend Favorite

The clinical development of paclitaxel and the paclitaxel/carboplatin combination

By Schwartz G.N.   Pendyala L.   Kindler H.   Meropol N.   Perez R.   Raghavan D.   Creaven P.  

European Journal of Cancer, Vol. 34, Iss. 10, 1998-09 ,pp. : 1543-1548

Elsevier

Access to resources Recommend Favorite

Induction chemotherapy with cetuximab, carboplatin and paclitaxel for the treatment of locally advanced squamous cell carcinoma of the head and neck

By                

Experimental and Therapeutic Medicine, Vol. 5, Iss. 4, 2013-01 ,pp. : 1247-1253

Spandidos Publications

Access to resources Recommend Favorite